<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rizzo, Toni</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Valgimigli, Marco</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Strategies to Optimize Antiplatelet Effects and Minimize Bleeding in NSTE-ACS</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">37-39</style></pages><abstract><style  face="normal" font="default" size="100%">Patients with non-ST-elevation (NSTE) acute coronary syndrome (ACS) are treated with antiplatelet and anticoagulation to reduce ischemic complications [Hamm CW et al. Eur Heart J 2011; Wright RS et al. J Am Coll Cardiol 2011]. This article discusses selecting the appropriate therapies and improving short- and long-term outcomes in patients with NSTE-ACS.</style></abstract><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>